An isolated antibody or antigen-binding fragment thereof that binds to the polypeptide of SEQ ID NO:9, wherein the antibody or antigen-binding fragment comprises: a) a heavy chain variable domain comprising a CDR1 region that comprises amino acids 31-35 of SEQ ID NO: 3, a CDR2 region that comprises amino acids 50-66 of SEQ ID NO: 3, and a CDR3 region that comprises amino acids 99-106 of SEQ ID NO: 3; and a light chain variable domain comprising a CDR1 region that comprises amino acids 24-38 of any one of SEQ ID NOs: 4, 11, or 12, a CDR2 region that comprises amino acids 54-60 of any one of SEQ ID NOs: 4, 11, or 12, and a CDR3 region that comprises amino acids 93-101 of any one of SEQ ID NOs: 4, 11 or 12; b) a heavy chain variable domain comprising a CDR1 region that comprises amino acids 31-35 of SEQ ID NO: 5, a CDR2 region that comprises amino acids 50-66 of SEQ ID NO: 5, and a CDR3 region that comprises amino acids 99-106 of SEQ ID NO: 5; and a light chain variable domain comprising a CDR1 region that comprises amino acids 24-38 of SEQ ID NO: 6, a CDR2 region that comprises amino acids 54-60 of SEQ ID NO: 6, and a CDR3 region that comprises amino acids 93-101 of SEQ ID NO: 6; or c) a heavy chain variable domain comprising a CDR1 region that comprises amino acids 31-35 of SEQ ID NO: 7, a CDR2 region that comprises amino acids 50-66 of SEQ ID NO: 7, and a CDR3 region that comprises amino acids 99-106 of SEQ ID NO: 7; and a light chain variable domain comprising a CDR1 region that comprises amino acids 24-38 of SEQ ID NO: 8, a CDR2 region that comprises amino acids 54-60 of SEQ ID NO: 8, and a CDR3 region that comprises amino acids 93-101 of SEQ ID NO: 8. a) a heavy chain variable domain comprising a CDR1 region that comprises amino acids 31-35 of SEQ ID NO: 3, a CDR2 region that comprises amino acids 50-66 of SEQ ID NO: 3, and a CDR3 region that comprises amino acids 99-106 of SEQ ID NO: 3; and a light chain variable domain comprising a CDR1 region that comprises amino acids 24-38 of any one of SEQ ID NOs: 4, 11, or 12, a CDR2 region that comprises amino acids 54-60 of any one of SEQ ID NOs: 4, 11, or 12, and a CDR3 region that comprises amino acids 93-101 of any one of SEQ ID NOs: 4, 11 or 12; b) a heavy chain variable domain comprising a CDR1 region that comprises amino acids 31-35 of SEQ ID NO: 5, a CDR2 region that comprises amino acids 50-66 of SEQ ID NO: 5, and a CDR3 region that comprises amino acids 99-106 of SEQ ID NO: 5; and a light chain variable domain comprising a CDR1 region that comprises amino acids 24-38 of SEQ ID NO: 6, a CDR2 region that comprises amino acids 54-60 of SEQ ID NO: 6, and a CDR3 region that comprises amino acids 93-101 of SEQ ID NO: 6; or c) a heavy chain variable domain comprising a CDR1 region that comprises amino acids 31-35 of SEQ ID NO: 7, a CDR2 region that comprises amino acids 50-66 of SEQ ID NO: 7, and a CDR3 region that comprises amino acids 99-106 of SEQ ID NO: 7; and a light chain variable domain comprising a CDR1 region that comprises amino acids 24-38 of SEQ ID NO: 8, a CDR2 region that comprises amino acids 54-60 of SEQ ID NO: 8, and a CDR3 region that comprises amino acids 93-101 of SEQ ID NO: 8.